Narcolepsy type 1 (NT1) has been shown to result from a selective loss of hypothalamic hypocretin-secreting neurons with patients typically showing low CSF-hypocretin levels (<110 pg/ml). The gene discussed is HCRT; the disease is narcolepsy-cataplexy syndrome.